Regulatory News has published 1 story about Shoulder Innovations on 19 September 2026, sourced to the primary record — the regulator’s decision, the company’s filing or its own announcement. This page is generated from that coverage. Last updated 19 September 2026.
This page is generated from Regulatory News’ editorial coverage of Shoulder Innovations. It is not an advertisement.
On the record
- Company
- Shoulder Innovations, Inc. (NYSE: SI)
- Headquarters
- Grand Rapids, Michigan
- Regulator
- U.S. Food and Drug Administration (CDRH)
Each line is taken from the most recent story of ours that states it.
Products in our coverage
Our coverage
